Safety and antitumor activity of recombinant soluble Apo2 ligand-Reference-Cited by-同舟云学术

Safety and antitumor activity of recombinant soluble Apo2 ligand

Published:1999-07-15 Issue:2 Volume:104 Page:155-162
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Ashkenazi Avi,Pai Roger C.,Fong Sharon,Leung Susan,Lawrence David A.,Marsters Scot A.,Blackie Christine,Chang Ling,McMurtrey Amy E.,Hebert Andrea,DeForge Laura,Koumenis Iphigenia L.,Lewis Derf,Harris Louise,Bussiere Jeanine,Koeppen Hartmut,Shahrokh Zahra,Schwall Ralph H.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference38 articles.

1. Programmed Cell Death in Animal Development

2. Apoptosis by Death Factor

3. Death Receptors: Signaling and Modulation

4. p53, the Cellular Gatekeeper for Growth and Division

5. Two TNF receptors

Cited by 1954 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pomalidomide sensitizes lung cancer cells to TRAIL/CDDP-induced apoptosis via directly targeting electron transfer flavoprotein alpha subunit;Bioorganic Chemistry;2024-12

2. E3 ubiquitin ligase gene BIRC3 modulates TNF-induced cell death pathways and promotes aberrant proliferation in rheumatoid arthritis fibroblast-like synoviocytes;Frontiers in Immunology;2024-09-05

3. Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma;Cell Reports Medicine;2024-08

4. Collapsed Star Copolymers Exhibiting Near Perfect Mimicry of the Therapeutic Protein “TRAIL”;Journal of the American Chemical Society;2024-07-26

5. The Role of TRAIL Signaling in Cancer: Searching for New Therapeutic Strategies;Biology;2024-07-15